Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Indonesian Adults, Adolescents, Children and Infants (Phase II)
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2019
Price : $35 *
At a glance
- Drugs Typhoid vaccine Vi DT conjugate International Vaccine Institute/Incepta/SK Bioscience/PT Biofarma (Primary)
- Indications Typhoid
- Focus Adverse reactions
- Sponsors PT Bio Farma
- 14 Mar 2019 Planned End Date changed from 30 Apr 2019 to 30 Jan 2020.
- 14 Mar 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.
- 14 Mar 2019 Status changed from recruiting to active, no longer recruiting.